Event Description
Please join us Thursday, May 4, 2023, for a Cell & Gene Therapy Symposium that will convene faculty from across Drexel University to present the latest developments from their research in this innovative area that is transforming medicine. This event is intended to raise awareness of the work underway in cell and gene therapy at Drexel and provide opportunities to build new collaborations and synergies across the University.
Schedule of Events
12-12:30 p.m.: Registration
12:30-1 p.m.: Welcome Remarks
-
John Fry, President
-
Aleister Saunders, Executive Vice Provost,
Research & Innovation
-
Raj Suri, Senior Vice Provost, Academic
Industry Partnerships
1-2:30 p.m.: Session I – Cell Therapy
-
Wendy
Clemens Trigona, Vice President, Bristol-Myers Squibb
-
Kara Spiller, School of
Biomedical Engineering, Science, and Health Systems, Immune cell therapy for regenerative medicine
-
Shaoping Hou, Department of Neurobiology &
Anatomy, College of Medicine,
Rebuilding supraspinal regulation of sympathetic input to improve cardio-electric disorders after spinal cord injury
-
Yinghui Zhong, School of Biomedical Engineering,
Science and Health Systems,
Biomaterial-enabled cell therapy for neuronal repair
-
Christopher Rodell, School of Biomedical
Engineering, Health and Science Systems, Biomaterials for cell therapy
-
Masoud Soroush, Department of Chemical and
Biological Engineering, College of Engineering, mRNA vaccine manufacturing
2:30-3 p.m.: Break
3-4:30 p.m.: Session II – Gene Therapy
-
Federico Mingozzi, Chief Science and Technology Officer, Spark
Therapeutics
-
Liang Oscar Qiang, Department of Neurobiology
& Anatomy, College of Medicine, Anti-sense oligonucleotides for neurodegenerative disease
-
Emanuela Piermarini,Department of
Neurobiology & Anatomy, College of Medicine, Gene therapy for neurodegenerative disease
-
William Dampier, Department of Microbiology &
Immunology, College of Medicine, Gene editing to cure HIV
-
Catherine Von Reyn, School of Biomedical
Engineering, Science & Health Systems, Optogenetic control of neurons
-
Wei-Heng Shih,Department of Materials
Science and Engineering, College of Engineering, RNA/DNA-based biosensors
-
Michele Kutzler, Departments of Medicine and
Microbiology & Immunology, College of Medicine, DNA vaccines for infectious disease
4:30-5:30 p.m.: Closing Remarks, Student
Poster Session, and Networking
-
Kara Spiller, Professor, School of Biomedical Engineering, Science and Health Systems
The event is open to the entire Drexel community and those outside
of cell and gene therapy are encouraged to attend. This event is organized by
the Office of the Provost, the Office of Research & Innovation and the
Drexel Solutions Institute. Cell and gene therapy represents an
area of Drexel expertise within Health Innovation, which has been identified as
an Area of Excellence and Opportunity (AEO) at the
University.
RSVP by April 27, 2023
|
